APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Decongestant

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nasal Decongestant Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchNasal Decongestant Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Decongestant Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Nasal Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Decongestant Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Decongestant Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nasal Decongestant market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nasal Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nasal Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nasal Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nasal Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nasal Decongestant include Abbott Laboratories, Glaxosmithkline, Bayer, Rugby Laboratories, Procter and Gamble, Patrick Parsons, Nidda Healthcare, Cipla and ADAPT Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nasal Decongestant, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nasal Decongestant, also provides the sales of main regions and countries. Of the upcoming market potential for Nasal Decongestant, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nasal Decongestant sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nasal Decongestant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nasal Decongestant sales, projected growth trends, production technology, application and end-user industry.

Nasal Decongestant Segment by Company

Abbott Laboratories

Glaxosmithkline

Bayer

Rugby Laboratories

Procter and Gamble

Patrick Parsons

Nidda Healthcare

Cipla

ADAPT Pharma

Nasal Decongestant Segment by Type

Nasal Strips

Capsule

Spray

Tablet

Nasal Decongestant Segment by Application

Nasal Allergies

Cold

Asthma

Nasal Decongestant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Decongestant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nasal Decongestant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nasal Decongestant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nasal Decongestant sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nasal Decongestant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nasal Strips Major Manufacturers Table 3. Capsule Major Manufacturers Table 4. Spray Major Manufacturers Table 5. Tablet Major Manufacturers Table 6. Global Nasal Decongestant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Nasal Allergies Major Manufacturers Table 8. Cold Major Manufacturers Table 9. Asthma Major Manufacturers Table 10. Nasal Decongestant Industry Trends Table 11. Nasal Decongestant Industry Drivers Table 12. Nasal Decongestant Industry Opportunities and Challenges Table 13. Nasal Decongestant Industry Restraints Table 14. Global Nasal Decongestant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Nasal Decongestant Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Nasal Decongestant Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Nasal Decongestant Revenue Market Share by Region (2021-2026) Table 18. Global Nasal Decongestant Revenue Market Share by Region (2027-2032) Table 19. Global Nasal Decongestant Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nasal Decongestant Sales by Region (2021-2026) & (K Units) Table 21. Global Nasal Decongestant Sales by Region (2027-2032) & (K Units) Table 22. Global Nasal Decongestant Sales Market Share by Region (2021-2026) Table 23. Global Nasal Decongestant Sales Market Share by Region (2027-2032) Table 24. Global Nasal Decongestant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Nasal Decongestant Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Nasal Decongestant Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Nasal Decongestant Sales Market Share by Manufacturers (2021-2026) Table 28. Global Nasal Decongestant Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Nasal Decongestant Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Nasal Decongestant Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Nasal Decongestant Manufacturers, Product Type & Application Table 32. Global Nasal Decongestant Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Nasal Decongestant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Nasal Decongestant Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Nasal Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Nasal Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Nasal Decongestant Revenue Market Share by Type (2021-2026) Table 39. Global Nasal Decongestant Revenue Market Share by Type (2027-2032) Table 40. Global Nasal Decongestant Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Nasal Decongestant Sales by Type (2021-2026) & (K Units) Table 42. Global Nasal Decongestant Sales by Type (2027-2032) & (K Units) Table 43. Global Nasal Decongestant Sales Market Share by Type (2021-2026) Table 44. Global Nasal Decongestant Sales Market Share by Type (2027-2032) Table 45. Global Nasal Decongestant Price by Type (2021-2026) & (US$/Unit) Table 46. Global Nasal Decongestant Price by Type (2027-2032) & (US$/Unit) Table 47. Global Nasal Decongestant Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nasal Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Nasal Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Nasal Decongestant Revenue Market Share by Application (2021-2026) Table 51. Global Nasal Decongestant Revenue Market Share by Application (2027-2032) Table 52. Global Nasal Decongestant Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Nasal Decongestant Sales by Application (2021-2026) & (K Units) Table 54. Global Nasal Decongestant Sales by Application (2027-2032) & (K Units) Table 55. Global Nasal Decongestant Sales Market Share by Application (2021-2026) Table 56. Global Nasal Decongestant Sales Market Share by Application (2027-2032) Table 57. Global Nasal Decongestant Price by Application (2021-2026) & (US$/Unit) Table 58. Global Nasal Decongestant Price by Application (2027-2032) & (US$/Unit) Table 59. Abbott Laboratories Company Information Table 60. Abbott Laboratories Business Overview Table 61. Abbott Laboratories Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Abbott Laboratories Nasal Decongestant Product Portfolio Table 63. Abbott Laboratories Recent Development Table 64. Glaxosmithkline Company Information Table 65. Glaxosmithkline Business Overview Table 66. Glaxosmithkline Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Glaxosmithkline Nasal Decongestant Product Portfolio Table 68. Glaxosmithkline Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bayer Nasal Decongestant Product Portfolio Table 73. Bayer Recent Development Table 74. Rugby Laboratories Company Information Table 75. Rugby Laboratories Business Overview Table 76. Rugby Laboratories Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Rugby Laboratories Nasal Decongestant Product Portfolio Table 78. Rugby Laboratories Recent Development Table 79. Procter and Gamble Company Information Table 80. Procter and Gamble Business Overview Table 81. Procter and Gamble Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Procter and Gamble Nasal Decongestant Product Portfolio Table 83. Procter and Gamble Recent Development Table 84. Patrick Parsons Company Information Table 85. Patrick Parsons Business Overview Table 86. Patrick Parsons Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Patrick Parsons Nasal Decongestant Product Portfolio Table 88. Patrick Parsons Recent Development Table 89. Nidda Healthcare Company Information Table 90. Nidda Healthcare Business Overview Table 91. Nidda Healthcare Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Nidda Healthcare Nasal Decongestant Product Portfolio Table 93. Nidda Healthcare Recent Development Table 94. Cipla Company Information Table 95. Cipla Business Overview Table 96. Cipla Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Cipla Nasal Decongestant Product Portfolio Table 98. Cipla Recent Development Table 99. ADAPT Pharma Company Information Table 100. ADAPT Pharma Business Overview Table 101. ADAPT Pharma Nasal Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. ADAPT Pharma Nasal Decongestant Product Portfolio Table 103. ADAPT Pharma Recent Development Table 104. North America Nasal Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Nasal Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Nasal Decongestant Sales by Type (2021-2026) & (K Units) Table 107. North America Nasal Decongestant Sales by Type (2027-2032) & (K Units) Table 108. North America Nasal Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 109. North America Nasal Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 110. North America Nasal Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Nasal Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Nasal Decongestant Sales by Application (2021-2026) & (K Units) Table 113. North America Nasal Decongestant Sales by Application (2027-2032) & (K Units) Table 114. North America Nasal Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 115. North America Nasal Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 116. North America Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Nasal Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Nasal Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. North America Nasal Decongestant Sales by Country (2021-2026) & (K Units) Table 121. North America Nasal Decongestant Sales by Country (2027-2032) & (K Units) Table 122. North America Nasal Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 123. North America Nasal Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 124. United States Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 125. Canada Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 126. Europe Nasal Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Nasal Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Nasal Decongestant Sales by Type (2021-2026) & (K Units) Table 129. Europe Nasal Decongestant Sales by Type (2027-2032) & (K Units) Table 130. Europe Nasal Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Nasal Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Nasal Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Nasal Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Nasal Decongestant Sales by Application (2021-2026) & (K Units) Table 135. Europe Nasal Decongestant Sales by Application (2027-2032) & (K Units) Table 136. Europe Nasal Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Nasal Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Nasal Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Nasal Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Europe Nasal Decongestant Sales by Country (2021-2026) & (K Units) Table 143. Europe Nasal Decongestant Sales by Country (2027-2032) & (K Units) Table 144. Europe Nasal Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Nasal Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 147. France Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 148. U.K. Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 149. Italy Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 151. China Nasal Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 152. China Nasal Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 153. China Nasal Decongestant Sales by Type (2021-2026) & (K Units) Table 154. China Nasal Decongestant Sales by Type (2027-2032) & (K Units) Table 155. China Nasal Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 156. China Nasal Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 157. China Nasal Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 158. China Nasal Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 159. China Nasal Decongestant Sales by Application (2021-2026) & (K Units) Table 160. China Nasal Decongestant Sales by Application (2027-2032) & (K Units) Table 161. China Nasal Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 162. China Nasal Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Nasal Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Nasal Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Nasal Decongestant Sales by Type (2021-2026) & (K Units) Table 166. Asia Nasal Decongestant Sales by Type (2027-2032) & (K Units) Table 167. Asia Nasal Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 168. Asia Nasal Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 169. Asia Nasal Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Nasal Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Nasal Decongestant Sales by Application (2021-2026) & (K Units) Table 172. Asia Nasal Decongestant Sales by Application (2027-2032) & (K Units) Table 173. Asia Nasal Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 174. Asia Nasal Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Nasal Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Nasal Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. Asia Nasal Decongestant Sales by Country (2021-2026) & (K Units) Table 180. Asia Nasal Decongestant Sales by Country (2027-2032) & (K Units) Table 181. Asia Nasal Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 182. Asia Nasal Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Japan Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 184. South Korea Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 185. India Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 186. Australia Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 187. China Taiwan Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Nasal Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Nasal Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Nasal Decongestant Sales by Type (2021-2026) & (K Units) Table 192. SAMEA Nasal Decongestant Sales by Type (2027-2032) & (K Units) Table 193. SAMEA Nasal Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 194. SAMEA Nasal Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 195. SAMEA Nasal Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Nasal Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Nasal Decongestant Sales by Application (2021-2026) & (K Units) Table 198. SAMEA Nasal Decongestant Sales by Application (2027-2032) & (K Units) Table 199. SAMEA Nasal Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 200. SAMEA Nasal Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 201. SAMEA Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Nasal Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Nasal Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. SAMEA Nasal Decongestant Sales by Country (2021-2026) & (K Units) Table 206. SAMEA Nasal Decongestant Sales by Country (2027-2032) & (K Units) Table 207. SAMEA Nasal Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 208. SAMEA Nasal Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 209. Brazil Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 210. Argentina Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 211. Chile Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 212. Colombia Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 213. Peru Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 215. Israel Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 216. UAE Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 217. Turkey Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 218. Iran Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 219. Egypt Nasal Decongestant Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Nasal Decongestant Distributors List Table 223. Nasal Decongestant Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Nasal Decongestant Image Figure 2. Global Nasal Decongestant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Decongestant Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nasal Strips Image Figure 5. Capsule Image Figure 6. Spray Image Figure 7. Tablet Image Figure 8. Global Nasal Decongestant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Nasal Decongestant Market Size Share 2021 VS 2025 VS 2032 Figure 10. Nasal Allergies Image Figure 11. Cold Image Figure 12. Asthma Image Figure 13. Global Nasal Decongestant Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nasal Decongestant Revenue (2021-2032) & (US$ Million) Figure 15. Global Nasal Decongestant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Nasal Decongestant Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Nasal Decongestant Revenue Market Share by Region (2021-2032) Figure 18. Global Nasal Decongestant Sales (2021-2032) & (K Units) Figure 19. Global Nasal Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Nasal Decongestant Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Nasal Decongestant Sales YoY (2021-2032) & (K Units) Figure 22. Europe Nasal Decongestant Sales YoY (2021-2032) & (K Units) Figure 23. China Nasal Decongestant Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Nasal Decongestant Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Nasal Decongestant Sales YoY (2021-2032) & (K Units) Figure 26. Global Nasal Decongestant Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Nasal Decongestant Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Nasal Decongestant Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Nasal Decongestant Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Nasal Decongestant Revenue Market Share by Type (2021-2032) Figure 32. Global Nasal Decongestant Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Nasal Decongestant Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Nasal Decongestant Sales Market Share by Type (2021-2032) Figure 35. Global Nasal Decongestant Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Nasal Decongestant Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Nasal Decongestant Revenue Market Share by Application (2021-2032) Figure 38. Global Nasal Decongestant Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Nasal Decongestant Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Nasal Decongestant Sales Market Share by Application (2021-2032) Figure 41. North America Nasal Decongestant Revenue Share by Type (2021-2032) Figure 42. North America Nasal Decongestant Sales Share by Type (2021-2032) Figure 43. North America Nasal Decongestant Revenue Share by Application (2021-2032) Figure 44. North America Nasal Decongestant Sales Share by Application (2021-2032) Figure 45. North America Nasal Decongestant Revenue Share by Country (2021-2032) Figure 46. North America Nasal Decongestant Sales Share by Country (2021-2032) Figure 47. Europe Nasal Decongestant Revenue Share by Type (2021-2032) Figure 48. Europe Nasal Decongestant Sales Share by Type (2021-2032) Figure 49. Europe Nasal Decongestant Revenue Share by Application (2021-2032) Figure 50. Europe Nasal Decongestant Sales Share by Application (2021-2032) Figure 51. Europe Nasal Decongestant Revenue Share by Country (2021-2032) Figure 52. Europe Nasal Decongestant Sales Share by Country (2021-2032) Figure 53. China Nasal Decongestant Revenue Share by Type (2021-2032) Figure 54. China Nasal Decongestant Sales Share by Type (2021-2032) Figure 55. China Nasal Decongestant Revenue Share by Application (2021-2032) Figure 56. China Nasal Decongestant Sales Share by Application (2021-2032) Figure 57. Asia Nasal Decongestant Revenue Share by Type (2021-2032) Figure 58. Asia Nasal Decongestant Sales Share by Type (2021-2032) Figure 59. Asia Nasal Decongestant Revenue Share by Application (2021-2032) Figure 60. Asia Nasal Decongestant Sales Share by Application (2021-2032) Figure 61. Asia Nasal Decongestant Revenue Share by Country (2021-2032) Figure 62. Asia Nasal Decongestant Sales Share by Country (2021-2032) Figure 63. SAMEA Nasal Decongestant Revenue Share by Type (2021-2032) Figure 64. SAMEA Nasal Decongestant Sales Share by Type (2021-2032) Figure 65. SAMEA Nasal Decongestant Revenue Share by Application (2021-2032) Figure 66. SAMEA Nasal Decongestant Sales Share by Application (2021-2032) Figure 67. SAMEA Nasal Decongestant Revenue Share by Country (2021-2032) Figure 68. SAMEA Nasal Decongestant Sales Share by Country (2021-2032) Figure 69. Nasal Decongestant Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Nasal Decongestant Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Strips
  • Capsule
  • Spray
  • Tablet
Applications
  • Nasal Allergies
  • Cold
  • Asthma
Companies covered
  • Abbott Laboratories
  • Glaxosmithkline
  • Bayer
  • Rugby Laboratories
  • Procter and Gamble
  • Patrick Parsons
  • Nidda Healthcare
  • Cipla
  • ADAPT Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nasal Decongestant Market by Type
  3. 1.2.1 Global Nasal Decongestant Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nasal Strips
  5. 1.2.3 Capsule
  6. 1.2.4 Spray
  7. 1.2.5 Tablet
  8. 1.3 Nasal Decongestant Market by Application
  9. 1.3.1 Global Nasal Decongestant Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Nasal Allergies
  11. 1.3.3 Cold
  12. 1.3.4 Asthma
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Nasal Decongestant Market Dynamics
  1. 2.1 Nasal Decongestant Industry Trends
  2. 2.2 Nasal Decongestant Industry Drivers
  3. 2.3 Nasal Decongestant Industry Opportunities and Challenges
  4. 2.4 Nasal Decongestant Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nasal Decongestant Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nasal Decongestant Revenue by Region
  3. 3.2.1 Global Nasal Decongestant Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nasal Decongestant Revenue by Region (2021-2026)
  5. 3.2.3 Global Nasal Decongestant Revenue by Region (2027-2032)
  6. 3.2.4 Global Nasal Decongestant Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nasal Decongestant Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nasal Decongestant Sales by Region
  9. 3.4.1 Global Nasal Decongestant Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nasal Decongestant Sales by Region (2021-2026)
  11. 3.4.3 Global Nasal Decongestant Sales by Region (2027-2032)
  12. 3.4.4 Global Nasal Decongestant Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nasal Decongestant Revenue by Manufacturers
  2. 4.1.1 Global Nasal Decongestant Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nasal Decongestant Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nasal Decongestant Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nasal Decongestant Sales by Manufacturers
  6. 4.2.1 Global Nasal Decongestant Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nasal Decongestant Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nasal Decongestant Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nasal Decongestant Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nasal Decongestant Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nasal Decongestant Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nasal Decongestant Manufacturers, Product Type & Application
  13. 4.7 Global Nasal Decongestant Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nasal Decongestant Market CR5 and HHI
  16. 4.8.2 2025 Nasal Decongestant Tier 1, Tier 2, and Tier 3
5 Nasal Decongestant Market by Type
  1. 5.1 Global Nasal Decongestant Revenue by Type
  2. 5.1.1 Global Nasal Decongestant Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nasal Decongestant Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nasal Decongestant Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nasal Decongestant Sales by Type
  6. 5.2.1 Global Nasal Decongestant Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nasal Decongestant Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nasal Decongestant Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nasal Decongestant Price by Type
6 Nasal Decongestant Market by Application
  1. 6.1 Global Nasal Decongestant Revenue by Application
  2. 6.1.1 Global Nasal Decongestant Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nasal Decongestant Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nasal Decongestant Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nasal Decongestant Sales by Application
  6. 6.2.1 Global Nasal Decongestant Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nasal Decongestant Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nasal Decongestant Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nasal Decongestant Price by Application
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories Nasal Decongestant Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Glaxosmithkline
  8. 7.2.1 Glaxosmithkline Company Information
  9. 7.2.2 Glaxosmithkline Business Overview
  10. 7.2.3 Glaxosmithkline Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Glaxosmithkline Nasal Decongestant Product Portfolio
  12. 7.2.5 Glaxosmithkline Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Nasal Decongestant Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Rugby Laboratories
  20. 7.4.1 Rugby Laboratories Company Information
  21. 7.4.2 Rugby Laboratories Business Overview
  22. 7.4.3 Rugby Laboratories Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Rugby Laboratories Nasal Decongestant Product Portfolio
  24. 7.4.5 Rugby Laboratories Recent Developments
  25. 7.5 Procter and Gamble
  26. 7.5.1 Procter and Gamble Company Information
  27. 7.5.2 Procter and Gamble Business Overview
  28. 7.5.3 Procter and Gamble Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Procter and Gamble Nasal Decongestant Product Portfolio
  30. 7.5.5 Procter and Gamble Recent Developments
  31. 7.6 Patrick Parsons
  32. 7.6.1 Patrick Parsons Company Information
  33. 7.6.2 Patrick Parsons Business Overview
  34. 7.6.3 Patrick Parsons Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Patrick Parsons Nasal Decongestant Product Portfolio
  36. 7.6.5 Patrick Parsons Recent Developments
  37. 7.7 Nidda Healthcare
  38. 7.7.1 Nidda Healthcare Company Information
  39. 7.7.2 Nidda Healthcare Business Overview
  40. 7.7.3 Nidda Healthcare Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nidda Healthcare Nasal Decongestant Product Portfolio
  42. 7.7.5 Nidda Healthcare Recent Developments
  43. 7.8 Cipla
  44. 7.8.1 Cipla Company Information
  45. 7.8.2 Cipla Business Overview
  46. 7.8.3 Cipla Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Cipla Nasal Decongestant Product Portfolio
  48. 7.8.5 Cipla Recent Developments
  49. 7.9 ADAPT Pharma
  50. 7.9.1 ADAPT Pharma Company Information
  51. 7.9.2 ADAPT Pharma Business Overview
  52. 7.9.3 ADAPT Pharma Nasal Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ADAPT Pharma Nasal Decongestant Product Portfolio
  54. 7.9.5 ADAPT Pharma Recent Developments
8 North America
  1. 8.1 North America Nasal Decongestant Market Size by Type
  2. 8.1.1 North America Nasal Decongestant Revenue by Type (2021-2032)
  3. 8.1.2 North America Nasal Decongestant Sales by Type (2021-2032)
  4. 8.1.3 North America Nasal Decongestant Price by Type (2021-2032)
  5. 8.2 North America Nasal Decongestant Market Size by Application
  6. 8.2.1 North America Nasal Decongestant Revenue by Application (2021-2032)
  7. 8.2.2 North America Nasal Decongestant Sales by Application (2021-2032)
  8. 8.2.3 North America Nasal Decongestant Price by Application (2021-2032)
  9. 8.3 North America Nasal Decongestant Market Size by Country
  10. 8.3.1 North America Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nasal Decongestant Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nasal Decongestant Market Size by Type
  2. 9.1.1 Europe Nasal Decongestant Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nasal Decongestant Sales by Type (2021-2032)
  4. 9.1.3 Europe Nasal Decongestant Price by Type (2021-2032)
  5. 9.2 Europe Nasal Decongestant Market Size by Application
  6. 9.2.1 Europe Nasal Decongestant Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nasal Decongestant Sales by Application (2021-2032)
  8. 9.2.3 Europe Nasal Decongestant Price by Application (2021-2032)
  9. 9.3 Europe Nasal Decongestant Market Size by Country
  10. 9.3.1 Europe Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nasal Decongestant Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Nasal Decongestant Market Size by Type
  2. 10.1.1 China Nasal Decongestant Revenue by Type (2021-2032)
  3. 10.1.2 China Nasal Decongestant Sales by Type (2021-2032)
  4. 10.1.3 China Nasal Decongestant Price by Type (2021-2032)
  5. 10.2 China Nasal Decongestant Market Size by Application
  6. 10.2.1 China Nasal Decongestant Revenue by Application (2021-2032)
  7. 10.2.2 China Nasal Decongestant Sales by Application (2021-2032)
  8. 10.2.3 China Nasal Decongestant Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nasal Decongestant Market Size by Type
  2. 11.1.1 Asia Nasal Decongestant Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nasal Decongestant Sales by Type (2021-2032)
  4. 11.1.3 Asia Nasal Decongestant Price by Type (2021-2032)
  5. 11.2 Asia Nasal Decongestant Market Size by Application
  6. 11.2.1 Asia Nasal Decongestant Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nasal Decongestant Sales by Application (2021-2032)
  8. 11.2.3 Asia Nasal Decongestant Price by Application (2021-2032)
  9. 11.3 Asia Nasal Decongestant Market Size by Country
  10. 11.3.1 Asia Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nasal Decongestant Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nasal Decongestant Market Size by Type
  2. 12.1.1 SAMEA Nasal Decongestant Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nasal Decongestant Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nasal Decongestant Price by Type (2021-2032)
  5. 12.2 SAMEA Nasal Decongestant Market Size by Application
  6. 12.2.1 SAMEA Nasal Decongestant Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nasal Decongestant Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nasal Decongestant Price by Application (2021-2032)
  9. 12.3 SAMEA Nasal Decongestant Market Size by Country
  10. 12.3.1 SAMEA Nasal Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nasal Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nasal Decongestant Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nasal Decongestant Value Chain Analysis
  2. 13.1.1 Nasal Decongestant Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nasal Decongestant Production Mode & Process
  6. 13.2 Nasal Decongestant Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nasal Decongestant Distributors
  9. 13.2.3 Nasal Decongestant Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst